AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Dibaglim M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Kasdap Healthcare Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Dibaglim M 1mg/500mg Tablet

Metformin/Sitagliptin 1mg/500mg tablets are classified as antidiabetic medications. This dual-drug formulation treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to hyperglycemia and potential complications including renal impairment, vision loss, neuropathy, and limb amputation. This medication is one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices are critical for diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect, manifested by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic potential. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal dysfunction. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating women should seek medical counsel before use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended.

Primary Ingredients of Dibaglim M 1mg/500mg Tablet

No text was provided to rephrase. Please provide the text you wish to have rewritten.

Uses of Dibaglim M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Dibaglim M 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet without chewing, crushing, or breaking it. The Dibaglim M 1mg/500mg Tablet should be administered with food.

Common Side effects of Dibaglim M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Dibaglim M 1mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. The Dibaglim M 1mg/500mg Tablet should be administered with food.

How Dibaglim M 1mg/500mg Tablet works:

Dibaglim M, a 1mg/500mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Dibaglim M 1mg/500mg tablets is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Dibaglim M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Consult your doctor for advice.

Breast feedingBreast feedingUNSAFE

Lactation and Dibaglim M 1mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Dibaglim M 1mg/500mg tablets, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated for individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Dibaglim M 1mg/500mg Tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Dibaglim M 1mg/500mg Tablet :

Should you forget a Dibaglim M 1mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dibaglim M 1mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Dibaglim M 1mg/500mg Tablet

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Dibaglim M 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue use and seek immediate medical attention.
Dibaglim M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It's not suitable for type 1 DM.
Dibaglim M 1mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Dibaglim M 1mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Dibaglim M 1mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Dibaglim M 1mg/500mg tablets with alcohol is unsafe. Alcohol can further reduce blood sugar, increasing the risk of hypoglycemia and lactic acidosis.
Dibaglim M 1mg/500mg Tabl...
74
MRP 90
17% off